background purpose carbon ion beams provide physical biological advantages photons study summarizes experiences carbon ion radiotherapy heavy ion medical accelerator chiba himac national institute radiological sciences materials methods june NUMBER august NUMBER total NUMBER patients various types malignant tumors enrolled phase studies clinical phase ii studies malignant glioma patients received carbon ion radiotherapy fraction number overall treatment time fixed tumor site given field day NUMBER NUMBER days week studies total dose escalated NUMBER NUMBER increments ensure safe patient treatment determine appropriate dose levels results initial studies severe late complications colon esophagus observed patients received high dose levels prostate uterine cervix esophageal cancer adverse effects did shortly disappear result determining safe dose levels improvements irradiation method carbon ion radiotherapy shown improvement outcome tumor entities locally advanced head neck tumors particular cell histology including adenocarcinoma adenoid cystic carcinoma malignant melanoma b early stage nsclc locally advanced nsclc c locally advanced bone soft tissue sarcomas suited surgical resection d locally advanced hepatocellular carcinomas e locally advanced prostate carcinomas particular patients f chordoma chondrosarcoma skull base cervical spine g pelvic recurrence rectal cancer treatment malignant gliomas pancreatic uterine cervix esophageal cancer investigated studies rationale use rt regimen superior dose localization unique biological properties beams proven treatment nsclc hepatoma fraction number successfully reduced fractions delivered weeks types tumors including prostate cancer tissue sarcoma tumors equally possible apply therapy shorter treatment times compared conventional rt regimen conclusion carbon ion radiotherapy physical biologic advantages photons provided improved outcome terms minimized toxicity high local control rates locally advanced tumors pathologically cell type tumors using carbon ion radiotherapy hypofractionated radiotherapy application larger doses fraction reduction overall treatment times compared conventional radiotherapy enabled dose escalation dose escalation dose escalation recto sigmoid non squamous high risk post operative dose escalation short course high let NUMBER NUMBER NUMBER NUMBER non squamous ii bone soft head neck